<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2026-01-29</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2026-01-29</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>51</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
å‘ç°ATRæŠ‘åˆ¶å‰‚å¯å¢å¼ºé»˜å…‹å°”ç»†èƒç™Œçš„è‚¿ç˜¤å…ç–«åŸæ€§ï¼›S1PR1åœ¨CD8+ Tç»†èƒè‚¿ç˜¤å…ç–«é€ƒé€¸ä¸­å‘æŒ¥éç»å…¸ä½œç”¨ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¢ç©¶AEG-1/MTDHåœ¨é«“ç³»ç»†èƒä¸­è°ƒæ§ä»£è°¢ç›¸å…³æ€§è„‚è‚ªæ€§è‚ç‚ï¼ˆMASHï¼‰çš„ä½œç”¨ã€‚<br />
- æ­ç¤ºhalofuginoneé€šè¿‡è°ƒæ§p-eIF2Î±-S100A8/A9-é’™ä¿¡å·é€šè·¯ï¼ŒæŠ‘åˆ¶è›‹ç™½åˆæˆï¼Œé€†è½¬æ€¥æ€§é«“ç³»ç™½è¡€ç—…è€è¯æœºåˆ¶ã€‚<br />
- é˜æ˜å‘¼å¸é“ç—…æ¯’æ„ŸæŸ“å¯¹è‚ºç™Œç”Ÿé•¿çš„ä¿ƒè¿›ä½œç”¨ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- ç©ºé—´è½¬å½•ç»„å­¦æŠ€æœ¯ç”¨äºåˆ†ææˆå¹´ä¸å˜æ€è¾èˆå¤§è„‘ã€‚<br />
- MitoPerturb-Seqå•ç»†èƒæŠ€æœ¯ç”¨äºç ”ç©¶çº¿ç²’ä½“DNAè€—ç«­å’Œå¼‚è´¨æ€§ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š</p>
</blockquote>
<p>æ·±åº¦å­¦ä¹ å·¥å…·åœ¨ç™Œç—‡è¯Šæ–­åŠåŸºå› ç»„ç ”ç©¶ä¸­å–å¾—çªç ´ï¼Œæ˜¾è‘—æå‡é•¿è¯»é•¿DNAå’ŒRNAæµ‹åºçš„çªå˜æ£€æµ‹èƒ½åŠ›ã€‚</p>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p>
<ul>
<li><strong>å•ç»†èƒRNAæµ‹åº</strong>ï¼šæ¯”è¾ƒä¸åŒæ ·æœ¬å¤ç”¨ç­–ç•¥å¯¹ä¸‹æ¸¸åˆ†æçš„å½±å“ï¼Œå…³æ³¨å…¶å¯¹ç»†èƒåº”æ¿€ã€è½¬å½•è¦†ç›–åº¦å’Œæ•°æ®è´¨é‡çš„æ”¹å˜ã€‚</li>
<li><strong>å¿ƒè¡€ç®¡ä¸è‚ é“å¥åº·</strong>ï¼šä¸€é¡¹æ–°ç»¼è¿°è¯å®é‡ç”Ÿè“è“å¯¹å¿ƒè¡€ç®¡å’Œè‚ é“å¥åº·æœ‰ç›Šï¼Œå°¤å…¶åœ¨æ”¹å–„è¡€ç®¡åŠŸèƒ½æ–¹é¢è¯æ®å……åˆ†ã€‚</li>
<li><strong>ç™Œç—‡è¯Šæ–­ä¸åŸºå› ç»„å­¦</strong>ï¼šå¼€å‘æ–°å‹æ·±åº¦å­¦ä¹ å·¥å…·ï¼Œç”¨äºæ›´ç²¾ç¡®çš„ç™Œç—‡è¯Šæ–­å’ŒRNAæ°´å¹³çš„å˜å¼‚åˆ†æã€‚</li>
</ul>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p>
<ul>
<li><strong>æ·±åº¦å­¦ä¹ æ¨¡å‹</strong>ï¼šClairS-TOå’ŒClair3-RNAç­‰æ–°å‹æ·±åº¦å­¦ä¹ å·¥å…·ï¼Œé©æ–°äº†é•¿è¯»é•¿æµ‹åºæ•°æ®çš„çªå˜æ£€æµ‹æ–¹æ³•ã€‚</li>
</ul>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (48æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE302842 æ˜Ÿå½¢èƒ¶è´¨ç»†èƒä¸­é«“ç³»ç»†èƒä¸­å‡é«˜çš„åŸºå› -1/Metadherin (AEG-1/MTDH) è°ƒèŠ‚ä»£è°¢åŠŸèƒ½éšœç¢ç›¸å…³çš„è„‚è‚ªæ€§è‚ç‚ (MASH) [ç©ºé—´è½¬å½•ç»„å­¦]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmetabolicã€spatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Devanand Sarkar ; Suchismita Raha ; Rachel Mendoza ; Xufeng Qu ; Jinze LiuSeries Type : OtherOrganism : Mus musculusAstrocyte elevated gene-1/Metadherin (AEG-1/MTDH) plays an important role in regulating lipid metabolism and inflammation in hepatocytes, and promotes metabolic dysfunction-associated steatohepatitis (MASH). Myeloid cells, such as macrophages, play a key role in regulating inflammation. Here we investigated the role of AEG-1 in myeloid cells in regulating high fat/high sugar diet (HF/HSD)-induced MASH. Both male and female AEG-1ï„MAC mice were significantly protected from MASH development compared to AEG-1fl/fl mice.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302842" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE313941 S1PR1 åœ¨ä»‹å¯¼è‚¿ç˜¤ä¸­ CD8 + T ç»†èƒåŠŸèƒ½éšœç¢ä¸­çš„éç»å…¸åŠŸèƒ½ [RNASeq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€T cellã€RNAseq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Debashree Basak ; Puspendu Ghosh ; Shilpak ChatterjeeSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusSphingosine-1-phosphate receptor 1 (S1PR1) signaling has been linked to the regulation of immunosuppressive cell populations within the tumor microenvironment (TME); however, its role in shaping anti-tumor CD8âº T cell responses remains poorly defined. Herein, we demonstrate that intratumoral CD8âº T cells express S1PR1, with expression predominantly enriched in the terminally exhausted subset. Transcriptomic profiling, combined with pharmacological inhibition and genetic knockdown, reveals that S1PR1-S1P signaling activates the PERK (protein kinase R (PKR)-like endoplasmic reticulum kinase)-CHOP (C/EBP homologous protein) axis of the endoplasmic reticulum stress response. CHOP, in turn, upregulates transcription of Map3k13 and Map3k15, triggering downstream MAPK signaling and culminating in activation of p38MAPK. Activation of this pathway impairs CD8âº T cell metabolism and effector function while increasing apoptotic susceptibility. This ultimately limits the persistence and accumulation of functional CD8âº T cells within the TME, thereby compromising their responsiveness to anti-PD-1 therapy. Targeting the S1PR1-S1P axis or its downstream effectors offers a promising strategy to improve cancer immunotherapy outcomes.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313941" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE311112 å•ç»†èƒ RNA æµ‹åºåˆ†ææ­ç¤ºäº†æ¥å—ä¼Šå¸ƒæ›¿å°¼æ²»ç–—çš„ CLL æ‚£è€…ä¸­ä¸åŒçš„è‚¿ç˜¤å’Œå…ç–«æŠ‘åˆ¶æ€§ T ç»†èƒè¡¨å‹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€RNA-seqã€single-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Shanmugapriya Thangavadivel ; Jami Shaffer ; Shrilekha Misra ; Samon Benrashid ; Britten K Gordon ; Alexander He ; Wantong Li ; Konur Oyman ; Annika Chura ; Shelby Cabrera ; Altan Turkoglu ; Tzung-Huei Lai ; Kerry A Rogers ; Seema A Bhat ; John C Byrd ; James S Blachly ; Jennifer A Woyach ; Bradley W BlaserSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Homo sapiensThe development of Bruton tyrosine kinase inhibitors (BTKi) and their introduction into clinical practice represents a major advance in the treatment of chronic lymphocytic leukemia (CLL). However, monotherapy with ibrutinib or other BTKis generally does not induce complete remissions or undetectable minimal residual disease (MRD) even with extended therapy. Therefore, there is a need to understand the differences between ibrutinib sensitive and resistant CLL cells along with the immune microenvironment to identify novel therapeutic approaches for controlling residual disease during BTKi treatment. Here, we investigated the cellular heterogeneity of peripheral blood mononuclear cells from patients with CLL treated with ibrutinib using single-cell RNA sequencing. We identified unique transcriptional heterogeneity within the B cell cluster in the ibrutinib-sensitive and resistant patients. Ibrutinib sensitive cells showed enrichment of B cell populations with upregulation of MHC I molecules and TNF family members. Additionally, we observed that inflammatory response and metabolism related pathways were decreased, whereas cellular response to stress and DNA repair programs were increased in the ibrutinib resistance samples. T cells in ibrutinib-resistant patients showed expansion of Tregs and an exhausted CD8 effector T cell compartment. Furthermore, CD14+ and CD16+ monocytes from ibrutinib resistant patients preferentially expressed a gene expression program of antiviral immunity. At the single-cell level, our findings demonstrate a picture of transcriptional heterogeneity in the tumor compartment and immune milieu. Overall, these findings suggest that T cell exhaustion and monocyte functional polarization may have a crucial role in BTKi resistance.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311112" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE309226 ä¸Šä¸‹æ–‡ä¾èµ–æ€§ç¿»è¯‘æŠ‘åˆ¶ä½œä¸ºä¸€ç§æ–°å‹è‚¿ç˜¤æ²»ç–—æ–¹å¼ [RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šoncologyã€regex:onco(logy|logist|gene|genic)ã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Paige D Diamond ; Paul V Sauer ; Mikael Holm ; Canessa J Swanson-Swett ; Lucas Ferguson ; Natalie M Bratset ; Grant W Wienker ; Justin S Sim ; Hailey K Adams ; Lillian Kenner ; Margot Meyers ; David Gygi ; Zef A KÃ¶nst ; Sogole S Bahmanyar ; Lawrence G Hamann ; Anthony P SchullerSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensInhibitors of protein synthesis, including anisomycin, homoharringtonine, and other natural products bind in the peptidyl-transferase center (PTC) of the eukaryotic ribosome to inhibit translation. Recent work has demonstrated that some PTC-binding antibiotics act in a sequence-selective manner, inhibiting translation elongation at specific amino acids while the polypeptide is engaged in the PTC. However, this phenomenon has yet to be documented for compounds that inhibit translation by the human ribosome. Here we use structure-based design to guide synthesis of molecules called interdictors that bind to the human ribosome PTC and act in a context-selective manner to inhibit translation elongation. Using ribosome profiling, in combination with in vitro biochemistry and cryo-electron microscopy, we characterize the context selectivity of unique analogues and observe their preferred interactions with nascent chain residues with complementary properties. Furthermore, we present a structure for an interdictor bound to a portion of the MYC protein at ~ 1.9 Ã… resolution and identify resulting structural rearrangements in both the nascent chain and ribosomal RNA. Finally, we document how these compounds differentially impact the ribotoxic stress response pathway which monitors ribosome collisions and can lead to apoptosis. Together, our data establish sequence-selective inhibition of translation as a novel small-molecule therapeutic modality for historically difficult to address cancers by targeting translation of oncogenic dependency factors in the human ribosome PTC.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309226" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE303946 å“ˆæ´›å¤«å‰é…®é€šè¿‡è°ƒèŠ‚ p-eIF2Î±-S100A8/A9-é’™ä¿¡å·ä¼ å¯¼ã€æŠ‘åˆ¶æ•´ä½“è›‹ç™½è´¨åˆæˆå’Œé€†è½¬æ€¥æ€§é«“ç³»ç™½è¡€ç—…å¯¹ä¼Šè¾¾æ¯”æ˜Ÿçš„è€è¯æ€§å‘æŒ¥å¹¿è°±ç»†èƒæ¯’æ€§ä½œç”¨ [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€resistanceã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Liuzhi Shi ; Yigang Yuan ; Bin Zhou ; Shenmeng Gao ; Liu Shi ; Min Zhao ; Yue CaiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusAlkaloid febrifugine., an herbal medicine in China, is prescribed routinely for malaria treatment. Halofuginone (HF), a natural product isolated from alkaloid febrifugine, exhibits anti-tumor and anti-inflammatory ability. Aim of the study: Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy with low overall survival (OS). Resistance to chemotherapeutic drugs such as idarubicin (IDA) results in treatment failure. This study investigated the role of HF in anti-AML ability and in overcoming IDA resistance in AML cells.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303946" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE317755 æˆå¹´å¢¨è¥¿å“¥é’å£èˆä¸å˜æ€å¢¨è¥¿å“¥é’å£èˆè„‘çš„ç©ºé—´è½¬å½•ç»„å­¦æ¯”è¾ƒ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Shuai Wang ; Sulei FuSeries Type : OtherOrganism : Ambystoma mexicanumThe Mexican axolotl (Ambystoma mexicanum) is an established model for studying tetrapod regeneration and development. Notably, axolotls exhibit remarkable brain regeneration as adults, a trait rarely observed in other adult vertebrates. Adult axolotls can undergo metamorphosis, a process that induces dramatic remodeling of multiple organs and is accompanied by a gradual decline in regenerative capacity and lifespan. However, systematic studies on whole-brain cellular dynamics and molecular mechanisms in both adult and metamorphosed individuals remain lacking. Here, we profiled five representative brain regions (olfactory bulb, telencephalon, diencephalon/mesencephalon, rhombencephalon, and pituitary) of the axolotl brain via spatial transcriptomics in both adult and metamorphosed individuals. Our work reveals metamorphosis-associated changes in cell types and molecular profiles across brain regions.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317755" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>GSE305869 è¡¨è§‚é—ä¼ ç¨‹åºå½±å“ä¸‰é˜´æ€§ä¹³è…ºç™Œçš„è‚ºç‰¹å¼‚æ€§è½¬ç§»</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€epigenetic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Diego M Marzese ; Pere LlinÃ s-Arias ; AndrÃ©s F Bedoya-LÃ³pezSeries Type : Methylation profiling by genome tiling arrayOrganism : Homo sapiensTriple-negative breast cancer (TNBC) is a major cause of cancer mortality, with distant metastases, particularly to the lung, presenting a significant clinical challenge. While epigenetic mechanisms like DNA methylation (DNAm) are known to influence TNBC progression, their specific role in driving metastasis remains underexplored. To address this gap, we present a comprehensive multi-omics analysis, integrating epigenomic and transcriptomic profiles from TNBC xenograft models and patient cohorts. Genome-wide DNAm profiling of primary tumors, lymph nodes, and lung metastases revealed pronounced global hypomethylation in lung lesions, consistent with clinical samples. Promoter-methylation changes were enriched in pathways linked to invasion and proliferation, and transcriptomic integration identified 22 epigenetically regulated genes. Among these, elevated AK1, SLC2A5, TPI1, and ZBTB17 expression correlated with a higher risk of lung dissemination. These findings highlight aberrant methylation as a driver of TNBC lung colonization and identify candidate prognostic markers, emphasizing the importance of epigenetic reprogramming in organ-specific metastasis.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305869" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE279158 Eè›‹ç™½Daughterlessè°ƒæ§æˆå¹´æœè‡ç¥ç»ç³»ç»Ÿä¸­çš„è›‹ç™½è´¨ç¿»è¯‘å’Œè®°å¿†[RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šnervousã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Laura Tamberg ; Carl Sander Kiir ; JÃ¼rgen Tuvikene ; KÃ¤thy Rannaste ; Mari Palgi ; Indrek Koppel ; TÃµnis TimmuskSeries Type : Expression profiling by high throughput sequencingOrganism : Drosophila melanogasterDaughterless (Da), the Drosophila melanogaster homolog of mammalian E-protein transcription factor 4 (TCF4), is well studied in fruit fly embryonic development but its functions in adult nervous system are poorly understood. Mutations in human TCF4 gene lead to intellectual disabilities such as Pitt-Hopkins syndrome and TCF4 has also been linked to schizophrenia. Here, to explore the roles of Da in the Drosophila mature brain, we map Da DNA binding sites and study the transcriptomics of the brains where Da function is inhibited by pan-neuronal Extramacrohaete (Emc) overexpression, in both male and female Drosophila Our transcriptome analyses reveal that in the adult brain Da regulates the expression of genes involved in behavior, memory, synaptic signaling, protein translation, and metabolic processes. Moreover, combining the RNA sequencing data with Da ChIP sequencing results indicates that genes associated with neuronal projection guidance, metabolism, and translation are direct targets of Da. In addition, we validate the involvement of Da in memory formation. Overall, our results provide valuable information about the functions of Da in the adult brain and aid in better understanding the mechanisms of TCF4-related disorders.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279158" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE317774 é»˜å…‹å°”ç»†èƒç™Œä¸­é€šè¿‡ATRæŠ‘åˆ¶å¢å¼ºè‚¿ç˜¤å…ç–«åŸæ€§çš„æœºåˆ¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€carcinoma<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Rashmi Bhakuni ; Junghyun Lee ; Peter Goff ; Daniel Jones ; Long Nguyen ; Rongxiang Lin ; Evan Newell ; Evan Hall ; Oren Gilad ; Eric J Brown ; Paul NghiemSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThere is an urgent unmet need to develop novel therapeutic strategies for tumors that do not respond to immune checkpoint inhibition (ICI) via PD-1 pathway blockade. The ATR-mediated DNA replication checkpoint has been reported to have immune-augmenting properties; however, the mechanisms underlying these properties are not well characterized. Here we explore the potential immunogenic effects of ATR inhibition in Merkel cell carcinoma (MCC), a cancer that is particularly relevant due to its high proliferative index and frequent response to anti-PD-(L)1 therapy. ATR inhibition induced tumor cell cytotoxicity in both Merkel cell polyomavirus-positive and UV-induced MCC cell lines in the absence of exogenous DNA damage. ATR inhibition alone or in combination with low-dose radiation induced numerous proinflammatory TNF-NF-ÎºB signals as assessed via bulk transcriptomic profiling. These included increased expression of MHC class-I alleles, antigen processing machinery, interleukins, chemokines and interferon genes associated with anti-tumor immune responses in diverse tumor types. In parallel, we observed enhanced surface exposure of the â€œeat-meâ€ signal calreticulin on MCC cells and subsequent phagocytosis by human monocyte-derived macrophages. Given that MCC tumors are often cGAS-STING-deficient (including two cell lines examined here), these ATRi-induced mechanisms are significant as they were activated regardless of cGAS-STING functional status. These data provide a mechanistic basis for the clinical evaluation of ATRi in advanced ICI-refractory MCC (NCT05947500), and suggest biomarkers that may be associated with response in human MCC tumors treated with ATRi.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317774" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE317577 å‘¼å¸é“ç—…æ¯’æ„ŸæŸ“ä¿ƒè¿›è‚ºç™ŒåŠ é€Ÿç”Ÿé•¿ [scATAC-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€scATAC<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xiaoqin Wei ; Wei Qian ; Xiangyu Ye ; Jie SunSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusThe COVID-19 pandemic has highlighted long-term health consequences of viral pneumonia, yet its potential impact on cancer development and growth remains poorly understood. Here, we show that prior SARS-CoV-2 or influenza infection accelerates lung tumor progression by reprogramming the local immune landscape. To test whether heightened cytokine responses after tumor initiation reflect durable epigenetic priming, we performed scATAC-seq on total lung cells from SARS-CoV-2â€“infected mice (28 d.p.i.) and PBS controls. Across macrophages, epithelial cells, fibroblasts, and endothelial cells, infection induced mild-to-moderate increases in chromatin accessibility at the Csf3 promoter and putative enhancers, with similar accessibility gains at Il6, Il1b, Cxcl1, and Cxcl5 loci in multiple compartments. Motif enrichment and regulon analyses further indicated increased accessibility/activity of NF-ÎºB and AP-1, along with elevated STAT3/STAT4 activity. Collectively, these data demonstrate that prior respiratory viral infection drives long-lasting epigenetic remodeling of cytokine loci in lung immune and structural cells.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317577" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 38 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>æ¯”è¾ƒå•ç»†èƒRNAæµ‹åºä¸­æ ·æœ¬å¤šé‡åŒ–æ–¹æ³•å¯¹ä¸‹æ¸¸åˆ†æçš„å½±å“</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€single-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šA head to head comparison of multiplexing strategies shows how workflow choice in RNA sequencing affects cell stress, transcript coverage, and data quality in cerebellar organoids...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/comparing-the-impact-of-sample-multiplexing-approaches-for-single-cell-rna-sequencing-on-downstream-analysis/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>æœ€æ–°ç ”ç©¶å‘ç°é‡ç”Ÿè“è“æœ‰ç›Šäºå¿ƒè„å’Œè‚ é“å¥åº·</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgutã€regex:gut(-?microbiome)?<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šA sweeping scientific review highlights wild blueberries as a standout food for cardiometabolic health. The strongest evidence shows improvements in blood vessel function, with encouraging signs for blood pressure, cholesterol, blood sugar, gut health, and cognition. Researchers suggest these benefits may kick in within hoursâ€”or build over weeksâ€”thanks to the berriesâ€™ unique mix of polyphenols and fiber.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/01/260127112125.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>ç ”ç©¶äººå‘˜å¼€å‘æ·±åº¦å­¦ä¹ å·¥å…·ï¼Œä»¥å˜é©ç™Œç—‡è¯Šæ–­å’ŒåŸºå› ç»„ç ”ç©¶ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šDeep-learning tools ClairS-TO and Clair3-RNA improve mutation detection from long-read DNA and RNA sequencing, enabling more accurate cancer diagnostics and RNA-level variant analysis...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/researchers-develop-deep-learning-tools-to-transform-cancer-diagnosis-and-genomic-research/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>cancer</td>
<td>14</td>
</tr>
<tr>
<td>sequencing</td>
<td>7</td>
</tr>
<tr>
<td>single-cell</td>
<td>6</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>6</td>
</tr>
<tr>
<td>tumor</td>
<td>3</td>
</tr>
<tr>
<td>T cell</td>
<td>3</td>
</tr>
<tr>
<td>RNAseq</td>
<td>3</td>
</tr>
<tr>
<td>regex:onco(logy</td>
<td>logist</td>
</tr>
<tr>
<td>metabolic</td>
<td>2</td>
</tr>
<tr>
<td>spatial</td>
<td>2</td>
</tr>
<tr>
<td>spatial transcriptomics</td>
<td>2</td>
</tr>
<tr>
<td>transcriptomics</td>
<td>2</td>
</tr>
<tr>
<td>nervous</td>
<td>2</td>
</tr>
<tr>
<td>carcinoma</td>
<td>2</td>
</tr>
<tr>
<td>immune</td>
<td>2</td>
</tr>
<tr>
<td>oncology</td>
<td>2</td>
</tr>
<tr>
<td>leukemia</td>
<td>2</td>
</tr>
<tr>
<td>resistance</td>
<td>2</td>
</tr>
<tr>
<td>methylation</td>
<td>2</td>
</tr>
<tr>
<td>epigenetic</td>
<td>1</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (38æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317576" target="_blank" rel="noopener noreferrer">GSE317576 å‘¼å¸é“ç—…æ¯’æ„ŸæŸ“ä¿ƒè¿›è‚ºç™ŒåŠ é€Ÿç”Ÿé•¿ [scRNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297416" target="_blank" rel="noopener noreferrer">GSE297416 MitoPerturb-Seq é‰´å®šå‡ºåŸºå› ç‰¹å¼‚æ€§çš„å•ç»†èƒå¯¹çº¿ç²’ä½“ DNA è€—ç«­å’Œå¼‚è´¨æ€§çš„ååº” [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294688" target="_blank" rel="noopener noreferrer">GSE294688 é¦–æ¬¡ç»†èƒåˆ†è£‚å‰ç»†èƒå› å­äº§ç”Ÿçš„æ—©æœŸçˆ†å‘å½±å“CD8 Tç»†èƒåˆ†åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285904" target="_blank" rel="noopener noreferrer">GSE285904 ä¸Šä¸‹æ–‡ä¾èµ–æ€§ç¿»è¯‘æŠ‘åˆ¶ä½œä¸ºä¸€ç§æ–°å‹è‚¿ç˜¤æ²»ç–—æ–¹å¼</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303795" target="_blank" rel="noopener noreferrer">GSE303795 å“ˆæ´›å¤«å‰é…®é€šè¿‡è°ƒèŠ‚ p-eIF2Î±-S100A8/A9-é’™ä¿¡å·é€šè·¯ã€æŠ‘åˆ¶æ•´ä½“è›‹ç™½è´¨åˆæˆä»¥åŠé€†è½¬æ€¥æ€§é«“ç³»ç™½è¡€ç—…ä¸­ä¼Šè¾¾æ¯”æ˜Ÿçš„è€è¯æ€§ï¼Œå‘æŒ¥å¹¿è°±ç»†èƒæ¯’æ€§ä½œç”¨ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281054" target="_blank" rel="noopener noreferrer">GSE281054 è¡¨å¾æˆå¹´æœè‡æ„Ÿå…‰ç»†èƒä¸­ç»„è›‹ç™½ç”²åŸºåŒ–çš„å¹´é¾„ä¾èµ–æ€§å˜åŒ–ï¼Œå¹¶ç¡®å®šTrrå’ŒTrxåœ¨ç»„è›‹ç™½ç”²åŸºåŒ–ä¸­çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE262534" target="_blank" rel="noopener noreferrer">GSE262534 é‰´å®š H3K4 ç”²åŸºåŒ–å¯¹è¡°è€æœè‡æ„Ÿå…‰ç»†èƒæ˜¼å¤œèŠ‚å¾‹é’Ÿçš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317485" target="_blank" rel="noopener noreferrer">GSE317485 å¾ªç¯ä¸­ç»æ¨¡æ‹Ÿç”µç©¿å­”å¤„ç†çš„CD2é‡ç”Ÿå‹å’ŒCD2æ•²é™¤å‹41BBzeta CART19ç»†èƒçš„å•ç»†èƒRNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315494" target="_blank" rel="noopener noreferrer">GSE315494 Tç»†èƒå—ä½“å·¥ç¨‹åŒ–Tç»†èƒé¶å‘TP53R248Qæ–°æŠ—åŸåœ¨äººç±»ç™Œç—‡æ¨¡å‹ä¸­è¯±å¯¼æŠ—è‚¿ç˜¤æ•ˆåº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302200" target="_blank" rel="noopener noreferrer">GSE302200 çŸ­æ—¶é«˜å¼ºåº¦æµä½“å‰ªåˆ‡åº”åŠ›è„‰å†²å¢å¼ºè½¬ç§»æ½œèƒ½å¹¶å¿«é€Ÿæ”¹å˜ç™Œç»†èƒä»£è°¢</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303672" target="_blank" rel="noopener noreferrer">GSE303672 å¯¹ DMD æ‚£è€… HSkM è‚Œç®¡è¿›è¡Œ RNA æµ‹åºï¼Œå‘ç°å…¨é•¿è‚Œè¥å…»ä¸è‰¯è›‹ç™½ (DP427) å’Œè‚Œè¥å…»ä¸è‰¯è›‹ç™½ (utrophin) å‡å­˜åœ¨å…±åŒçš„è½¬å½•ç»„æ”¹å˜ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302723" target="_blank" rel="noopener noreferrer">GSE302723 æ˜Ÿå½¢èƒ¶è´¨ç»†èƒä¸­å‡é«˜åŸºå› -1/Metadherin (AEG-1/MTDH) åœ¨é«“ç³»ç»†èƒä¸­è°ƒèŠ‚ä»£è°¢åŠŸèƒ½éšœç¢ç›¸å…³è„‚è‚ªæ€§è‚ç‚ (MASH)</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289357" target="_blank" rel="noopener noreferrer">GSE289357 å¯¹ç¼ºä¹è‚Œè¥å…»ä¸è‰¯è›‹ç™½å’Œè‚Œè¥å…»è›‹ç™½çš„ HeLa ç»†èƒè¿›è¡Œ RNA æµ‹åºï¼Œæ­ç¤ºäº†é‡å çš„è½¬å½•ç»„æ”¹å˜</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279107" target="_blank" rel="noopener noreferrer">GSE279107 Eè›‹ç™½Daughterlessè°ƒæ§æˆå¹´æœè‡ç¥ç»ç³»ç»Ÿä¸­çš„è›‹ç™½è´¨ç¿»è¯‘å’Œè®°å¿†</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE262182" target="_blank" rel="noopener noreferrer">GSE262182 RNAæµ‹åºåˆ†æç¦é£Ÿå°é¼ çš„éª¨é«“æµ†ç»†èƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE262108" target="_blank" rel="noopener noreferrer">GSE262108 RNAæµ‹åºåˆ†æKDå¤„ç†å°é¼ çš„éª¨é«“æµ†ç»†èƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317334" target="_blank" rel="noopener noreferrer">GSE317334 è„‘è†œæ·‹å·´ç®¡åŠŸèƒ½éšœç¢é€šè¿‡å†…è´¨ç½‘å’Œæ°§åŒ–åº”æ¿€é€”å¾„åŠ å‰§ CVST å°é¼ çš„è„‘æŸä¼¤ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313357" target="_blank" rel="noopener noreferrer">GSE313357 æµ·é©¬é›Œæ¿€ç´ æ°´å¹³ã€å—ä½“ç±»å‹å’Œè¡¨è§‚é—ä¼ å­¦å¯¼è‡´æ€§åˆ«ç‰¹å¼‚æ€§è®°å¿†å¯¹åŒæ—¶å‘ç”Ÿçš„æ€¥æ€§åº”æ¿€çš„è„†å¼±æ€§[RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309403" target="_blank" rel="noopener noreferrer">GSE309403 CD4+ T ç»†èƒä»‹å¯¼ BCMA CAR ç–—æ³•åçš„ CAR å…ç–«ç›¸å…³ä¸è‰¯äº‹ä»¶ (CirAE)</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299943" target="_blank" rel="noopener noreferrer">GSE299943 BCL-xL ä½œä¸ºè¥¿å¦¥æ˜”å•æŠ—è€è¯æ€§ç»“ç›´è‚ ç™Œçš„æ²»ç–—é¶ç‚¹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297491" target="_blank" rel="noopener noreferrer">GSE297491 MitoPerturb-Seq é‰´å®šå‡ºåŸºå› ç‰¹å¼‚æ€§çš„å•ç»†èƒå¯¹çº¿ç²’ä½“ DNA è€—ç«­å’Œå¼‚è´¨æ€§çš„ååº” [DamID]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297418" target="_blank" rel="noopener noreferrer">GSE297418 MitoPerturb-Seq é‰´å®šåŸºå› ç‰¹å¼‚æ€§å•ç»†èƒå¯¹çº¿ç²’ä½“ DNA è€—ç«­å’Œå¼‚è´¨æ€§çš„ååº” [å¤šç»„]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317733" target="_blank" rel="noopener noreferrer">GSE317733 snFLARE-seq å’Œ mrFRIGID ç”¨äºç ”ç©¶ä¸åŒè§£å‰–èµ·æºçš„å‰åˆ—è…ºç™Œçš„è½¬å½•ç»„å’Œä»£è°¢ç»„å›¾è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270576" target="_blank" rel="noopener noreferrer">GSE270576 å‡èšç´ -ä»‹ä½“ç›¸äº’ä½œç”¨åœ¨æœ‰ä¸åˆ†è£‚æŸ“è‰²ä½“ç»„ç»‡ä¸­çš„ä½œç”¨ [Hi-C]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270574" target="_blank" rel="noopener noreferrer">GSE270574 å‡èšç´ -ä»‹ä½“ç›¸äº’ä½œç”¨åœ¨æœ‰ä¸åˆ†è£‚æŸ“è‰²ä½“ç»„ç»‡ä¸­çš„ä½œç”¨ [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317681" target="_blank" rel="noopener noreferrer">GSE317681 æ¥å—å¸•åšè¥¿å°¼æ²»ç–—çš„ HR+/HER2- è½¬ç§»æ€§ä¹³è…ºç™Œæ‚£è€…çš„åŸºå› ç»„è¯„ä¼°ï¼ˆPROMISE ç ”ç©¶ï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317628" target="_blank" rel="noopener noreferrer">GSE317628 æ¥å—å¸•åšè¥¿å°¼æ²»ç–—çš„ HR+/HER2- è½¬ç§»æ€§ä¹³è…ºç™Œæ‚£è€…çš„åŸºå› ç»„è¯„ä¼°ï¼ˆPROMISE ç ”ç©¶ï¼‰é…å¯¹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317499" target="_blank" rel="noopener noreferrer">GSE317499 æµ·é©¬CA2åŒºç¥ç»å…ƒå‘¨å›´ç½‘çŠ¶ç»“æ„çš„é€€åŒ–è§£é‡Šäº†é˜¿å°”èŒ¨æµ·é»˜ç—…ä¸­ç¤¾ä¼šè®¤çŸ¥è®°å¿†çš„ä¸§å¤±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317494" target="_blank" rel="noopener noreferrer">GSE317494 é¶å‘ç»†èƒç”Ÿç‰©èƒ½é‡å­¦çš„åŒé‡ç–—æ³•æ²»ç–—èƒ°è…ºç™Œ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317469" target="_blank" rel="noopener noreferrer">GSE317469 YTHDC1æ•²ä½è¯±å¯¼çš„ä¸‰é˜´æ€§ä¹³è…ºç™Œç»†èƒåŸºå› è¡¨è¾¾å˜åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317443" target="_blank" rel="noopener noreferrer">GSE317443 å¤šç»„å­¦ SMR å’Œå®éªŒæ”¯æŒæ€§åˆ†ææ­ç¤ºè‚ç»†èƒç™Œçš„å› æœé©±åŠ¨å› ç´ </a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317433" target="_blank" rel="noopener noreferrer">GSE317433 å‰åˆ—è…ºç™Œéª¨è½¬ç§»ä¸­17q11.2é«˜é¢‘ç¼ºå¤±å’Œç™Œç—‡è½¬ç§»æŠ‘åˆ¶microRNA miR-193a-3pçš„ä¸‹è°ƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317345" target="_blank" rel="noopener noreferrer">GSE317345 æ¥å—å¸•åšè¥¿å°¼æ²»ç–—çš„ HR+/HER2- è½¬ç§»æ€§ä¹³è…ºç™Œæ‚£è€…çš„åŸºå› ç»„è¯„ä¼°ï¼ˆPROMISE ç ”ç©¶ï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313168" target="_blank" rel="noopener noreferrer">GSE313168 çªå˜çš„æˆçº¤ç»´ç»†èƒç”Ÿé•¿å› å­å—ä½“ 1 æ˜¯é«˜å±ç¥ç»æ¯ç»†èƒç˜¤çš„è‡´ç™Œé©±åŠ¨å› ç´ å’Œæ²»ç–—é¶ç‚¹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308689" target="_blank" rel="noopener noreferrer">GSE308689 æ•´åˆåº”æ¿€ååº”é€šâ€‹â€‹è¿‡è„‚è´¨è¿è½½è›‹ç™½2ä¿ƒè¿›å…ç–«é€ƒé€¸</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290122" target="_blank" rel="noopener noreferrer">GSE290122 ç”¨ç™½è‰²å¿µç èŒæ„ŸæŸ“çš„è½½ä½“å’Œ rmMETRNL å°é¼ å·¨å™¬ç»†èƒçš„ä¸‹ä¸€ä»£æµ‹åºåˆ†æã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290121" target="_blank" rel="noopener noreferrer">GSE290121 å¯¹ç»ç™½è‰²å¿µç èŒå¤„ç†çš„METRNL+/+(WT)å’ŒMETRNL-/-(METRNL KO)å·¨å™¬ç»†èƒè¿›è¡Œä¸‹ä¸€ä»£æµ‹åºåˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290120" target="_blank" rel="noopener noreferrer">GSE290120 å¤–å‘¨è¡€å•æ ¸ç»†èƒçš„ä¸‹ä¸€ä»£æµ‹åºåˆ†æï¼ˆå¯¹ç…§å°é¼ ä¸å…¨èº«æ€§ç™½è‰²å¿µç èŒæ„ŸæŸ“å°é¼ ï¼‰</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-01-28 21:50</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>